http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#Head http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#assertion http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#provenance http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#pubinfo http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#assertion http://purl.obolibrary.org/obo/MONDO_0007079 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0007079 http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB01273 http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association http://www.w3.org/2000/01/rdf-schema#label Only a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin, ondansetron, varenicline, baclofen, sodium oxybate and antidepressants. http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#cohort http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28658981/ http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#cohort http://www.w3.org/2000/01/rdf-schema#label Adults http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort https://go.drugbank.com/drugs/DB01273 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#provenance http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#pubinfo http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#sig http://purl.org/nanopub/x/hasSignature LJdYfmQQOrzzHKY5Vt/jV8W2a9n6KSRc/Vj7n9g2dBVeD9OBpZpLrqeIjOhs1QfRWGZ/fljT0vNiUgOPG/vnp93VwLAFnPiDfj24d8pQBLckJCp6J9a2hXQhGlekeGF+hkc8sR7r2NHjdsz5Uq6Ax1clmSrG4XkI4Xdw6PqbAiI= http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 http://purl.org/dc/terms/created 2021-05-26T12:53:00.485+02:00 http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAXXGaQh1eWkq3LQF4GUp4bdfBwS4OlfO1f7UMNHYHIL0 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg